Lutetium-177 labeled iPD-L1 as a novel immunomodulator for cancer-targeted radiotherapyMyrna Luna‐Gutiérrez, Guillermina Ferro‐Flores|EJNMMI Radiopharmacy and Chemistry|2025Cited by 8